Published in Medical Letter on the CDC and FDA, May 1st, 2005
The sNDA was filed on September 28, 2004 and was granted priority review status by the FDA. This new indication makes ZOFRAN the only medication approved to prevent postoperative nausea and vomiting (PONV) and chemotherapy-induced nausea and vomiting (CINV) in infants, the company says. ZOFRAN was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.